US delays small imports rule that raised alarm over prescription drug costs

The US has delayed the implementation of a small imports rule that had sparked concerns regarding the rising costs of prescription drugs. This strategic postponement is intended to prevent higher prices for imported medications and various other products for Americans struggling with inflation. By delaying the rule, the government ensures that these potential price increases do not take effect until after the November midterm elections, providing temporary financial relief to consumers across the country.